Axsome Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
Provided By GlobeNewswire
Last update: May 5, 2025
Total 1Q 2025 net product revenue of $121.5 million, representing 62% year-over-year growth
AUVELITY® 1Q 2025 net product sales of $96.2 million, representing 80% year-over-year growth
Read more at globenewswire.com
